West Pharmaceutical Services WST Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's net income?
- West Pharmaceutical Services (WST) reported net income of $154M in Q2 2026.
- How has West Pharmaceutical Services's net income changed year-over-year?
- West Pharmaceutical Services's net income increased by 16.8% year-over-year, from $131.8M to $154M.
- What is the long-term trend for West Pharmaceutical Services's net income?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's net income has grown at a -7.1% compound annual growth rate (CAGR), from $661.8M to $493.7M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.